• Publications
  • Influence
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.
Recommendations are made regarding diagnostic measures to screen for iron- and other anemia-related deficiencies regarding the triggers for medical intervention, treatment goals, and appropriate therapies. Expand
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
This is the first European Crohn’s and Colitis Organisation [ECCO] consensus guideline that addresses extra-intestinal manifestations in inflammatory bowel disease [IBD] and represents consensus with agreement of at least 80% of participants. Expand
Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease
Serum levels of adiponectin, resistin, and active ghrelin are increased whereas serum levels of leptin are decreased in patients with IBD, and no association between serum adipocytokines levels and disease localization in both UC and CD patients was found. Expand
Mean platelet volume: a useful marker of inflammatory bowel disease activity
Mean platelet volume is significantly reduced in active inflammatory bowel disease and is negatively correlated with the knowninflammatory bowel disease activity markers and the platelet activation products. Expand
Ischemic colitis: clinical practice in diagnosis and treatment.
Ischemic colitis is the most common form of ischemic injury of the gastrointestinal tract and can present either as an occlusive or a non-occlusive form. It accounts for 1 in 1000 hospitalizationsExpand
Environmental risk factors in inflammatory bowel disease.
The available data suggest that UC and CD are heterogeneous disorders of multifactorial etiology in which hereditary and environmental factors interact to produce the disease. Expand
Allelic polymorphism in IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) genes in inflammatory bowel disease
The results suggest that the IL‐1β/IL‐1Ra allelic cluster may participate in defining the biological basis of predisposition to chronic inflammatory bowel diseases. Expand
Diagnosing anemia in inflammatory bowel disease: beyond the established markers.
This review discusses the newer alternative markers for iron status that may be useful when serum ferritin and Tsat are not sufficient and erythrocytes parameters like the red cell distribution width and the percentage of hypochromic red cells as well as reticulocyte parameters could be useful markers for the evaluation of anemia in IBD. Expand
Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries: A Systematic Review and Individual Patient Data Meta-analysis
The overall prevalence of anemia in patients with Crohn's disease was 27% and 21% (95% confidence interval, 15–27) in Patients with ulcerative colitis, and 57% of the anemic patients were iron deficient. Expand